FDA Drugs recall ·
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only… recall
- Recall number
- D-0043-2025
- Date
- (initiated October 23, 2024)
- Company / brand
- Cipla USA, Inc.
10 Independence Blvd, Warren, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 1,875 boxes (cipla and exlan)
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98
Why was it recalled?
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot # NB240316, Exp 12/31/25
Distribution
USA nationwide.
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0043-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.